EiR Blog

A Blog For Those Affected By Environmental And Invisible Illnesses Written By Fellow Survivors

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Login
    Login Login form

Fecal-transplant startup Rebiotix closes on $25M for trials

Posted by Posted on in EirBlog
  • Font size: Larger Smaller
  • Hits: 3482
  • Print



Biotech startup Rebiotix has raised $25 million in capital to fund clinical trials of its fecal-transplant technology.

The Roseville-based company raised the funding from individual investors, CEO Lee Jones said.

Rebiotix transplants bacteria from healthy stool into patients suffering from C. difficile, a bacterial infection that’s typically acquired during hospital stays.

In addition to clinical trials, the recent round of funding will go toward research and development and working capital, Rebiotixsaid.

The company will present results from an earlier clinical trial in October.

Last year, the Food and Drug Administration accepted Rebiotix’s productinto its fast-track program, which could expedite the technology’s approval for sale.

Rebiotix has now raised $30 million since launching in 2011.Katharine Grayson covers med tech, clean tech, technology, health care and venture capital.



Read More: http://www.bizjournals.com/twincities/blog/in_private/2014/08/fecal-transplant-startup-rebiotix-clinical-trials.html?s=image_gallery





Fecal-transplant startup Rebiotix closes on $25M for trialsDynamic Neural Retraining Program (DNRS)


Rate this blog entry:



  • No comments found

Leave your comments

Post comment as a guest

0 Character restriction
Your text should be more than 25 characters
Your comments are subjected to administrator's moderation.
terms and condition.